DCGI approves Phase III trials of Zydus Cadila Covid vaccine
NEW DELHI [Maha Media]: Drug Controller General of India (DCGI) has approved Phase III human trial of pharmaceutical company Zydus Cadila for the the Corona vaccine.
The company informed on Friday that the third phase of human trials for its Corona vaccine will begin this month. This test will be done at 20 to 25 centres across the country.
Zydus Cadila stated that going by the results of the second phase of human testing, the vaccine is effective. Only one dose of this vaccine will be given.